Treatment Registry
TR-0810 ActiveRecorded September 2026

Compounded semaglutide

Sold by ReadyRx · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPer monthCharged today
First month, discounted (site shows a crossed-out reference price beside it)Introductory

“From $179$249 /first mo.”

Per month$179Charged today$179
Price sources
Visit ReadyRx

We earn nothing from this link. It opens ReadyRx's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

CancellationYou may cancel a subscription at any time by emailing support@readyrx.com and directly requesting a cancellation. Cancellation will take effect at the end of the current subscription period.

Not yet checked: pharmacy, states, prescriber, membership and consult fee.

Recorded from readyrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The product page is titled 'GLP-1 Injection Rx' and never names semaglutide vs. tirzepatide in the price block itself; it is tied to semaglutide only via a separate FAQ heading on the same page, 'What are the benefits of Semaglutide?'. There is no equivalent tirzepatide product page (nav only lists GLP-1 Injections, Glutathione, Metformin under 'Metabolic health'). The $179/$249 figure is rendered as adjacent strikethrough text in the DOM ('$179$249'), read here as a discounted first-month price against a $249 reference price; a banner also advertises 'LIMITED TIME DEAL: Extra $20 Off - Code: GETHEALTHY26', not applied here. Ongoing (non-promotional) monthly price is never stated. Controls show 'Monthly / Quarterly / One-time' tabs but clicking Quarterly did not change the visible price block.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0810
Medication category
compounded semaglutide
Readings
1

Cite this entry

Treatment Registry. (2026). ReadyRx — compounded semaglutide (TR-0810). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0810

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.